CYCLOBENZAPRINE HYDROC
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This contract is for the procurement of Cyclobenzaprine Hydrochloride 10 mg tablets, regulated by the FDA and intended for oral administration. The order consists of 48 bottles under NSN 6505010628010, with a delivery requirement of 5 days after order. The product must be stored at controlled room temperature between 20 and 25 degrees Celsius and must have a total shelf life of 24 months, with at least 21 months remaining upon receipt by the government. Compliance requires adherence to DLA packaging and medical marking standards, specifically MMS No. 1. All units must be securely packaged in sealed containers to prevent damage during transit to the destination. The contract specifies a zero percent quantity variance and requires the contracting official to coordinate with a product specialist for confirmation of bidder and manufacturer details.
General Info
Agency
NAICS
Place of Performance
4258 CAMP BURTON RD, MC LEANSVILLE, NC, 27301-0000, USASet-Aside
Documents
(1)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Response Deadline
Organization & Contact Information
Full Description
CYCLOBENZAPRINE HYDROCHLORIDE TABLETS, USP, CYCLOBENZAPRINE HCL 10 MG
TAB 100.
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
RX ONLY, FOR ORAL ADMINISTRATION UNIT OF ISSUE"BOTTLE" TOTAL SHELF LIFE
IS 24 MONTHS.. THERE SHALL BE A MINIMUM OF 21 MONTHS OF REMAINING SHELF
LIFE AT THE TIME OF RECEIPT BY THE FIRST GOVERNMENT ACTIVITY.. STORE AT
20° TO 25°C (68° TO 77°F) SEE USP CONTROLLED ROOM TEMPERATURE
MARK IN ACCORDANCE WITH MMS No. 1B 30 March 2017 . This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
SPE2DP-26-T-4660
SECTION B
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
SOLCO HEALTHCARE US LLC 0JQ27 P/N NDC43547-0400-10 JUBILANT CADISTA PHARMACEUTICALS INC. 441M0 P/N NDC59746-0177-06 CIPLA USA INC 7WV84 P/N NDC69097-0846-07 PD-RX PHARMACEUTICALS, INC. 0PTU3 P/N NDC72789-0036-01
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017889897 0001 BT 48.000
NSN/MATERIAL:6505010628010
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-062-8010 Quantity: 48 BT Purchase Request: 7017889897QTY: 48 Delivery: 5 days ADO
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
